New pill shows promise for controlling rare swelling disorder
NCT ID NCT05505916
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the long-term safety of an oral medication called KVD900 for treating swelling attacks in people with hereditary angioedema (HAE) types I or II. The trial enrolled 145 adolescents and adults who had already completed a previous study. Participants took KVD900 tablets as needed during an attack. The main goal was to track side effects and lab results over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
KVD900 (an oral plasma kallikrein inhibitor)
What this could lead to
If successful, this could provide a convenient, on-demand oral treatment option for hereditary angioedema attacks, reducing the need for injections.
What could go wrong
This is an extension trial focused on safety, not proof of effectiveness. The drug may still have side effects or not work for everyone. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KalVista Investgative Site
Layton, Utah, 84041, United States
-
KalVista Investgative Site
Tokyo, 142-8666, Japan
-
KalVista Investigative Site
Scottsdale, Arizona, 85251, United States
-
KalVista Investigative Site
Little Rock, Arkansas, 72205, United States
-
KalVista Investigative Site
San Diego, California, 92122, United States
-
KalVista Investigative Site
San Diego, California, 92123, United States
-
KalVista Investigative Site
Santa Monica, California, 90404, United States
-
KalVista Investigative Site
Centennial, Colorado, 80112, United States
-
KalVista Investigative Site
Colorado Springs, Colorado, 80907, United States
-
KalVista Investigative Site
Evansville, Indiana, 47715, United States
-
KalVista Investigative Site
Overland Park, Kansas, 66211, United States
-
KalVista Investigative Site
Louisville, Kentucky, 40215, United States
-
KalVista Investigative Site
Chevy Chase, Maryland, 20815, United States
-
KalVista Investigative Site
Plymouth, Minnesota, 55446, United States
-
KalVista Investigative Site
St Louis, Missouri, 63141, United States
-
KalVista Investigative Site
Charlotte, North Carolina, 28277, United States
-
KalVista Investigative Site
Cincinnati, Ohio, 45236, United States
-
KalVista Investigative Site
Toledo, Ohio, 43617, United States
-
KalVista Investigative Site
Hershey, Pennsylvania, 17033, United States
-
KalVista Investigative Site
Dallas, Texas, 75231, United States
-
KalVista Investigative Site
Spokane, Washington, 99204, United States
-
KalVista Investigative Site
Campbelltown, 2560, Australia
-
KalVista Investigative Site
Wein, 1090, Austria
-
KalVista Investigative Site
Sofia, 1431, Bulgaria
-
KalVista Investigative Site
Montreal, H2W 1R7, Canada
-
KalVista Investigative Site
Grenoble, 38043, France
-
KalVista Investigative Site
Lille, 59037, France
-
KalVista Investigative Site
Paris, 75012, France
-
KalVista Investigative Site
Berlin, 12203, Germany
-
KalVista Investigative Site
Frankfurt, 60590, Germany
-
KalVista Investigative Site
Mainz, 55131, Germany
-
KalVista Investigative Site
Mörfelden-Walldorf, 64546, Germany
-
KalVista Investigative Site
Athens, 11521, Greece
-
KalVista Investigative Site
Athens, 11527, Greece
-
KalVista Investigative Site
Budapest, 1088, Hungary
-
KalVista Investigative Site
Haifa, 31048, Israel
-
KalVista Investigative Site
Petach Tikvah, 4920235, Israel
-
KalVista Investigative Site
Ramat Gan, 52621, Israel
-
KalVista Investigative Site
Tel Aviv, 64239, Israel
-
KalVista Investigative Site
Padova, 35128, Italy
-
KalVista Investigative Site
Palermo, 90146, Italy
-
KalVista Investigative Site
Roma, 00133, Italy
-
KalVista Investigative Site
San Donato Milanese, 20097, Italy
-
KalVista Investigative Site
Sapporo, Hokkaido, 002-8072, Japan
-
KalVista Investigative Site
Chiba, 260-8677, Japan
-
KalVista Investigative Site
Hiroshima, 730-8518, Japan
-
KalVista Investigative Site
Kawagoe-shi, 350-8550, Japan
-
KalVista Investigative Site
Maebashi, 371-8511, Japan
-
KalVista Investigative Site
Soka-shi, 340-0041, Japan
-
KalVista Investigative Site
Takatsuki-shi, 569-8686, Japan
-
KalVista Investigative Site
Yokohama, 236-0004, Japan
-
KalVista Investigative Site
Amsterdam, 1105 AZ, Netherlands
-
KalVista Investigative Site
Auckland, 1023, New Zealand
-
KalVista Investigative Site
Skopje, 1000, North Macedonia
-
KalVista Investigative Site
Krakow, 31-503, Poland
-
KalVista Investigative Site
Lodz, 92-213, Poland
-
KalVista Investigative Site
Porto, 4200-319, Portugal
-
KalVista Investigative Site
Sângeorgiu de Mureş, 547530, Romania
-
KalVista Investigative Site
Riyadh, 11211, Saudi Arabia
-
KalVista Investigative Site
Martin, 036 59, Slovakia
-
KalVista Investigative Site
Barcelona, 08035, Spain
-
KalVista Investigative Site
Barcelona, 08907, Spain
-
KalVista Investigative Site
Madrid, 28046, Spain
-
KalVista Investigative Site
Birmingham, B9 5SS, United Kingdom
-
KalVista Investigative Site
Cambridge, CB2 0QQ, United Kingdom
-
KalVista Investigative Site
Cardiff, CF14 4XW, United Kingdom
-
KalVista Investigative Site
Frimley, GU16 7UJ, United Kingdom
-
KalVista Investigative Site
Leeds, LS9 7TF, United Kingdom
-
KalVista Investigative Site
London, E1 2ES, United Kingdom
-
KalVista Investigative Site
London, NW3 2QG, United Kingdom
-
Kalvista Investigative Site
Cape Town, 7700, South Africa